Does NOVALGIN Cause Agranulocytosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with NOVALGIN. This represents 26.3% of all adverse event reports for NOVALGIN.
5
Reports of Agranulocytosis with NOVALGIN
26.3%
of all NOVALGIN reports
2
Deaths
3
Hospitalizations
How Dangerous Is Agranulocytosis From NOVALGIN?
Of the 5 reports, 2 (40.0%) resulted in death, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NOVALGIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NOVALGIN Cause?
Atrial septal defect (6)
Macrocephaly (6)
Neonatal respiratory distress syndrome (6)
Pulmonary artery stenosis congenital (6)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)